Refractory Lymphoproliferative Disorder
1 clinical trials · Condition
◉ Watch Refractory Lymphoproliferative Disorder
| Record | Firm | Date |
|---|---|---|
| Leflunomide for the Treatment of Relapsed or Refractory CD30+ Lymphoproliferative Disorders (NCT04463615) | City of Hope Medical Center | 2021-05-05 |
Track Refractory Lymphoproliferative Disorder automatically
Every clearance here is in the API, with alerts when new ones post.